Clearmind MedicineCMND
About: Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
Employees: 1
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
13% more funds holding
Funds holding: 8 [Q3] → 9 (+1) [Q4]
0% less capital invested
Capital invested by funds: $5.49M [Q3] → $5.49M (-$3.11K) [Q4]
3.31% less ownership
Funds ownership: 17.3% [Q3] → 13.99% (-3.31%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for CMND.
Financial journalist opinion









